In advanced clinical practice, up to 4/5th of the hospitalized patients require intravenous therapy at some point during their hospital stay. This intravenous route can involve administering ...

Feb. 1, 2005 -- The U.S. Food and Drug Administration (FDA) has issued a nationwide warning against the use of preloaded syringes containing either heparin or sodium chloride intravenous catheter ...

Stage-Specific Outcomes of Patients With Uterine Leiomyosarcoma: A Comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems During ...

SwabFlush combines SwabCap and the ZR Catheter Flush Syringe into one device, to make it easier for nurses to flush, disinfect and protect the IV connector all at the same time. (Photo: Business Wire) ...

The Food and Drug Administration (FDA) has approved DefenCath ® (taurolidine and heparin) catheter lock solution to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult ...

Central venous catheters (CVCs) are critical components in modern clinical practice, providing essential vascular access for fluid administration, medication delivery, and haemodynamic monitoring in ...

NORTHFIELD, Ill.--(BUSINESS WIRE)--According to the CDC, considerable progress is being made in preventing central line associated blood stream infections, but further improvement is still needed. An ...

April 5, 2005 — The European Commission has approved for use in the European Union a second-generation embolic protection system for use in saphenous vein graft interventional procedures; the Japanese ...

OBJECTIVES: The optimal method for epinephrine administration during neonatal resuscitation is not known. We hypothesized that epinephrine will be delivered more efficiently when administered via a ...

The FDA approved a taurolidine and heparin (DefenCath) catheter lock solution for reducing the risk of bloodstream infections in patients on dialysis. Approved under a special limited agency pathway, ...

NEPTUNE, N.J.--(BUSINESS WIRE)--Excelsior Medical Corporation announced today that it has received FDA 510(k) clearance for SwabFlush™, its latest product for the vascular access and infection control ...